In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Resolve Therapeutics, a US-based healthcare provider, has raised $5.8m in its series B round from a consortium including venture firms New Science Ventures and Easton Capital and WRF Capital, the university venturing unit of Washington Research Foundation.
In May 2010, Resolve raised $2m in the initial close of its A round before planning on bringing in a corporate venturing unit later.
New Science Ventures and Easton Capital provided the initial A round that had been expected to bring in a…
